BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barros MS, de Araújo ND, Magalhães-Gama F, Pereira Ribeiro TL, Alves Hanna FS, Tarragô AM, Malheiro A, Costa AG. γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends. Front Immunol 2021;12:729085. [PMID: 34630403 DOI: 10.3389/fimmu.2021.729085] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Dong T, Wu N, Gao H, Liang S, Dong X, Zhao T, Jiang Q, Liu J. CD277 agonist enhances the immunogenicity of relapsed/refractory acute myeloid leukemia towards Vδ2+ T cell cytotoxicity. Ann Hematol 2022. [PMID: 35920929 DOI: 10.1007/s00277-022-04930-8] [Reference Citation Analysis]
2 Chan KF, Duarte JDG, Ostrouska S, Behren A. γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells. Front Immunol 2022;13:894315. [DOI: 10.3389/fimmu.2022.894315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Poggi A, Zocchi MR. Anti-cancer γδ T lymphocytes: contradictory past and promising future. Explor Immunol 2022. [DOI: 10.37349/ei.2022.00047] [Reference Citation Analysis]
4 Kong X, Zheng J, Liu X, Wang W, Jiang X, Chen J, Lai J, Jin Z, Wu X. High TRGV 9 Subfamily Expression Marks an Improved Overall Survival in Patients With Acute Myeloid Leukemia. Front Immunol 2022;13:823352. [PMID: 35222403 DOI: 10.3389/fimmu.2022.823352] [Reference Citation Analysis]
5 Handgretinger R, Lang P, Queudeville M. The role of γδ T cells in the context of allogeneic stem cell transplantation. Explor Immunol 2022. [DOI: 10.37349/ei.2022.00041] [Reference Citation Analysis]
6 Zarobkiewicz MK, Bojarska-Junak AA. The Mysterious Actor-γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL). Cells 2022;11:661. [PMID: 35203309 DOI: 10.3390/cells11040661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]